2A Biosciences Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.78M

  • Investors
  • 13

2A Biosciences General Information

Description

Developer of proprietary small-molecule drug candidates designed for regenerative and anti-inflammatory therapeutic outcomes. The company's platform uses precise molecular designs to develop non-hallucinogenic compounds that selectively activate the Serotonin 2A receptor, modulating biological processes related to neuroregeneration, mitochondrial biogenesis, and inflammation resolution, enabling individuals suffering from a range of degenerative and chronic inflammatory diseases, such as neurodegenerative eye conditions, to access novel, disease-modifying treatment options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1714 Bryn Mawr
  • Santa Monica, CA 90405
  • United States
+1 (917)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1714 Bryn Mawr
  • Santa Monica, CA 90405
  • United States
+1 (917)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

2A Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 26-Jul-2023 $3.78M Completed Clinical Trials - Phase 1
1. Seed Round 01-Jan-2022 Completed Clinical Trials - Phase 1
To view 2A Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

2A Biosciences Patents

2A Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198728-A1 1,3-dihydro-4-isobenzofuranethanamines Pending 18-Mar-2025
WO-2025240982-A1 5-alkoxymethyl and 5-hydroxymethyl phenethylamines Pending 17-May-2024
US-12692221-B2 5-methoxymethyl and 5-hydroxymethyl phenethylamines Active 17-May-2024
US-20250353808-A1 5-methoxymethyl and 5-hydroxymethyl phenethylamines Active 17-May-2024
WO-2025217471-A1 2-hemifly phenethylamines Pending 10-Apr-2024 A61P25/28
To view 2A Biosciences’s complete patent history, request access »

2A Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

2A Biosciences Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boost VC Accelerator/Incubator Minority
Calm Ventures Venture Capital Minority
Capital Factory Accelerator/Incubator Minority
DecentraNet Venture Capital Minority
Gaingels Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

2A Biosciences FAQs

  • When was 2A Biosciences founded?

    2A Biosciences was founded in 2022.

  • Where is 2A Biosciences headquartered?

    2A Biosciences is headquartered in Santa Monica, CA.

  • What is the size of 2A Biosciences?

    2A Biosciences has 10 total employees.

  • What industry is 2A Biosciences in?

    2A Biosciences’s primary industry is Drug Discovery.

  • Is 2A Biosciences a private or public company?

    2A Biosciences is a Private company.

  • What is 2A Biosciences’s current revenue?

    The current revenue for 2A Biosciences is .

  • How much funding has 2A Biosciences raised over time?

    2A Biosciences has raised $3.78M.

  • Who are 2A Biosciences’s investors?

    Boost VC, Calm Ventures, Capital Factory, DecentraNet, and Gaingels are 5 of 13 investors who have invested in 2A Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process